Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Stomach Neoplasms 19Carcinoma, Hepatocellular 18Pancreatic Neoplasms 14Colorectal Neoplasms 12Esophageal Neoplasms 9Neoplasm Metastasis 8Esophageal Squamous Cell Carcinoma 7Biliary Tract Neoplasms 7Lung Neoplasms 6Liver Neoplasms 6Cholangiocarcinoma 6Breast Neoplasms 6Neoplasms 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Melanoma 3Sarcoma 2Rectal Neoplasms 2Advanced Pancreatic Cancer 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Resectable Esophageal Squamous Cell Carcinoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Cancer Metastatic 1Ovarian Neoplasms 1Oligometastatic Gastrointestinal Cancer 1

Interventions

exemestane 1Injections 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tuberous Sclerosis × Injections × Gastrointestinal × Clear all
NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

SAPU NANO (US) LLC

Phase 1 Recruiting
27 enrolled
EndocrineGastrointestinalGenitourinaryNET

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡